From Nasdaq: 2025-06-20 12:06:00

Validea’s guru fundamental report for ABBOTT LABORATORIES (ABT) shows that it rates highest using the P/E/Growth Investor model based on Peter Lynch’s strategy. ABT is a large-cap growth stock in the Medical Equipment & Supplies industry, with a rating of 87% based on fundamentals and valuation. The stock meets most criteria of Lynch’s strategy, including P/E ratio, inventory to sales, EPS growth rate, and total debt/equity ratio. Lynch, a legendary investor, is known for his common sense approach to investing. Validea is an investment research service that follows the strategies of investment legends like Lynch.



Read more at Nasdaq: Peter Lynch Detailed Fundamental Analysis – ABT